改变分次放疗方式可克服患者来源胶质母细胞瘤细胞的放射抵抗:基于新型纵向放射细胞毒性检测
研究结合计算机数学模拟与体外实验,用患者来源异种移植脑肿瘤起始细胞比较恒定分次(CDF)与动态分次(DDF)方案。结果显示递减分次(RD:7、5、3、1 Gy)在克服获得性放射抵抗方面最有效,相对细胞存活率与存活分数均显著低于CDF(P < 0.0001)。
要点
- 递减分次方案(RD)在克服脑肿瘤起始细胞获得性放射抵抗方面最有效。
- 相对细胞存活率与存活分数CDF vs RD均P < 0.0001。
- 新型纵向检测可同时进行分次间纵向分析与终点分析。
核心结论
- 利用计算机细胞毒性预测模型与改良放射敏感性评估,DDF-RD在三种放射敏感性不同的脑肿瘤起始细胞系中均有效诱导细胞毒性。
研究设计与样本
- 研究将理论计算机数学假设与体外实验策略相结合,以探究替代放疗方案。
- 采用患者来源异种移植脑肿瘤起始细胞,分别接受假照射对照及三种总名义剂量与平均剂量均为16 Gy(分四次)但每次剂量不同的方案。
- 分次方式为常规恒定分次(CDF:4、4、4、4 Gy)、动态分次递减(RD:7、5、3、1 Gy)或动态分次递增(RU:1、3、5、7 Gy),每4天一次。
- 每5天对细胞成像收集分次间纵向数据,第20天取终点存活率。
主要发现
- 所提出的放射敏感性评估方法除终点分析外,还可进行分次间纵向研究。
- 以RD方式给予四次分次剂量在克服脑肿瘤起始细胞获得性放射抵抗方面最有效(相对细胞存活率:CDF vs RD,P < 0.0001;存活分数:CDF vs RD,P < 0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Current radiotherapy (RT) in glioblastoma (GBM) is delivered as constant dose fractions (CDF), which do not account for intratumoral-heterogeneity and radio-selection in GBM. These factors contribute to differential treatment response complicating the therapeutic efficacy of this principle. Our study aims to investigate an alternative dosing strategy to overcome radio-resistance using a novel longitudinal radiation cytotoxicity assay. METHODS: Theoretical In-silico mathematical assumptions were combined with an in-vitro experimental strategy to investigate alternative radiation regimens. Patient-derived xenograft (PDX) brain tumor-initiating cells (BTICs) with differential radiation-sensitivities were tested individually with sham control and three regimens of the same nominal and average dose of 16 Gy (over four fractions), but with altered doses per fraction. Fractions were delivered conventionally (CDF: 4, 4, 4, 4 Gy), or as dynamic dose fractions (DDF) "ramped down" (RD: 7, 5, 3, 1 Gy), or DDF "ramped up" (RU: 1, 3, 5, 7 Gy), every 4 days. Interfraction-longitudinal data were collected by imaging cells every 5 days, and endpoint viability was taken on day 20. RESULTS: The proposed method of radiosensitivity assessment allows for longitudinal-interfraction investigation in addition to endpoint analysis. Delivering four-fraction doses in an RD manner proves to be most effective at overcoming acquired radiation resistance in BTICs (Relative cell viability: CDF vs. RD: P < 0.0001; Surviving fraction: CDF: vs. RD: P < 0.0001). CONCLUSIONS: Using in-silico cytotoxicity prediction modeling and an altered radiosensitivity assessment, we show DDF-RD is effective at inducing cytotoxicity in three BTIC lines with differential radiosensitivity.
引用
- Nassour-Caswell LC, Kumar M, Stackhouse CT, et al. Altering fractionation during radiation overcomes radio-resistance in patient-derived glioblastoma cells assessed using a novel longitudinal radiation cytotoxicity assay. Radiother Oncol. 2024. PMID: 39579870. doi:10.1016/j.radonc.2024.110646
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。